Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
2015 · The International Journal of Neuropsychopharmacology · 226 citations
https://doi.org/10.1093/ijnp/pyv124
P
Paul Glue
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
315
Papers
9.6K
Citations
54
h-index
175
i10-index
Paul Glue is an academic researcher from University of Otago. The author has contributed to research in topics: Treatment of Major Depression & Tryptophan and brain disorders & Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes. The author has an h-index of 54, co-authored 268 publications.
ORCID: 0000-0002-7305-2800Papers by this author
worksKetamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders
2017 · Journal of Psychopharmacology · 142 citations
https://doi.org/10.1177/0269881117705089
An improved human anxiety process biomarker: characterization of frequency band, personality and pharmacology
2015 · Translational Psychiatry · 65 citations
https://doi.org/10.1038/tp.2015.188
Right frontal anxiolytic-sensitive EEG ‘theta’ rhythm in the stop-signal task is a theory-based anxiety disorder biomarker
2021 · Scientific Reports · 59 citations
https://doi.org/10.1038/s41598-021-99374-x
A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder
2009 · BMC Medical Research Methodology · 58 citations
https://doi.org/10.1186/1471-2288-9-55
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
2024 · Nature Medicine · 42 citations
https://doi.org/10.1038/s41591-024-03063-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat